Hemorheology, plasma protein composition and von Willebrand Factor in type I diabetic nephropathy

被引:0
|
作者
Zimmermann, J
Schramm, L
Wanner, C
Mulzer, E
Henrich, HA
Langer, R
Heidbreder, E
机构
[1] UNIV WURZBURG,DEPT MED,D-97080 WURZBURG,GERMANY
[2] UNIV WURZBURG,DEPT SURG,D-97080 WURZBURG,GERMANY
[3] UNIV WURZBURG,DIV EXPT SURG,D-97080 WURZBURG,GERMANY
关键词
nephropathy; hemorheology; blood viscosity; plasma viscosity; erythrocyte aggregation; erythrocyte deformability; fibrinogen; von Willebrand Factor;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with IDDM, especially those with albuminuria are at high risk for macrovascular and microvascular complications. Besides the major classic risk factors altered hemorheology may also play a role. Plasma viscosity, erythrocyte aggregation and erythrocyte deformability are the major determinants of blood flow in the microcirculation. Therefore, these hemorheological parameters and plasma protein composition were evaluated in 58 IDDM-patients with none (N0), incipient (N1: albuminuria 30-300 mg/day) and overt clinical nephropathy (N2: albuminuria >300 mg/day). As an estimate of endothelial injury plasma levels of von Willebrand Factor (vWF) were investigated. Patients with incipient and clinical nephropathy exhibited increasing blood levels of fibrinogen (N0=2.47+/-0.09, N1=2.71+/-0.15, N2=3.49+/-0.24 g/l, p <0.001), alpha(2)-macroglobulin (N0=257+/-11, N1=251+/-21, N2=382+/-43 mg/100 ml, p <0.01) and haptoglobin (N0=174+/-16, N1=216+/-39, N2=278+/-36 mg/100 ml, p <0.05), whereas serum albumin concentration decreased (N0=5.1+/-0.1, N1=4.7+/-0.1, N2=4.1+/-0.2 g/100 ml, p <0.001). In the same patients erythrocyte aggregation (N0=10.0+/-0.4, N1=12.1+/-0.5, N2=12.9+/-0.6, p <0.001), plasma viscosity (N0=1.34+/-0.01, N1=1.38+/-0.02, N2=1.40+/-0.02 mPas, p <0.05) and erythrocyte rigidity (N0=0.05+/-0.01, N1=0.15+/-0.05, N2=0.09+/-0.02, p <0.05) were increased, predominantly in those with overt clinical nephropathy. Erythrocyte aggregation was positively correlated with plasma concentrations of fibrinogen (r=0.65, p <0.001) and alpha(2)-macroglobulin (r=0.35, p <0.05), but negatively with plasma albumin concentration (r=-0.49, p <0.001). Plasma viscosity was positively correlated with plasma concentrations of fibrinogen (r=0.46, p <0.001) and haptoglobin (r=0.46, p <0.001). Von Willebrand Factor levels were higher in patients with overt clinical nephropathy (N0=126+/-8, N1=136+/-12, N2=163+/-14%, p <0.09, P-N0-N2 <0.05). A significant correlation between vWF and the rheological determinants could not be detected. These data demonstrate that blood rheology is profoundly altered in patients with IDDM and nephropathy. Elevated levels of vWF may indicate endothelial damage, and changes in plasma viscosity as well as erythrocyte aggregability seem to be the result of altered plasma protein composition due to proteinuria. These abnormalities in hemorheology may be an aggravating factor promoting microvascular and macrovascular damage in patients with type I diabetes mellitus and nephropathy.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 50 条
  • [41] The safety of plasma-derived von Willebrand/factor VIII concentrates in the management of inherited von Willebrand disease
    Federici, Augusto B.
    EXPERT OPINION ON DRUG SAFETY, 2009, 8 (02) : 203 - 210
  • [42] Plasma concentration of von Willebrand factor in acute myocardial infarction
    Sakai, H
    Goto, S
    Kim, JY
    Aoki, N
    Abe, S
    Ichikawa, N
    Yoshida, M
    Nagaoka, Y
    Handa, S
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (02) : 204 - 209
  • [43] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
    Rugeri, Lucia
    Thomas, Will
    Schirner, Kathrin
    Heyder, Lisa
    Auerswald, Guenter
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
  • [44] Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases
    Lu Guo-yuan
    Shen Lei
    Wang Zhao-yue
    Guo Xiao-fang
    Bai Xia
    Su Jian
    Ruan Chang-geng
    CHINESE MEDICAL JOURNAL, 2008, 121 (02) : 133 - 136
  • [45] Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A New Insights into Factor VIII-von Willebrand Factor Interactions
    Jacquemin, Marc
    ACTA HAEMATOLOGICA, 2009, 121 (2-3) : 102 - 105
  • [46] Platelet adhesion on commercially pure titanium plates in vitro I: effects of plasma components and involvement of the von Willebrand factor and fibronectin
    Akira Takahashi
    Shotaro Takahashi
    Tetsuhiro Tsujino
    Kazushige Isobe
    Taisuke Watanabe
    Yutaka Kitamura
    Takao Watanabe
    Koh Nakata
    Tomoyuki Kawase
    International Journal of Implant Dentistry, 5
  • [47] Platelet adhesion on commercially pure titanium plates in vitro I: effects of plasma components and involvement of the von Willebrand factor and fibronectin
    Takahashi, Akira
    Takahashi, Shotaro
    Tsujino, Tetsuhiro
    Isobe, Kazushige
    Watanabe, Taisuke
    Kitamura, Yutaka
    Watanabe, Takao
    Nakata, Koh
    Kawase, Tomoyuki
    INTERNATIONAL JOURNAL OF IMPLANT DENTISTRY, 2019, 5 (1)
  • [48] Effect of desmopressin on plasma factor VIII and von Willebrand factor concentrations in Greyhounds
    Sato, I
    Parry, BW
    AUSTRALIAN VETERINARY JOURNAL, 1998, 76 (12) : 809 - 812
  • [49] Evidence for the Misfolding of the Al Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease
    Tischer, Alexander
    Brehm, Maria A.
    Machha, Venkata R.
    Moon-Tasson, Laurie
    Benson, Linda M.
    Nelton, Katelynn J.
    Leger, Rachel R.
    Obser, Tobias
    Martinez-Vargas, Marina
    Whitten, Steven T.
    Chen, Dong
    Pruthi, Rajiv K.
    Bergen, H. Robert, III
    Cruz, Miguel A.
    Schneppenheim, Reinhard
    Auton, Matthew
    JOURNAL OF MOLECULAR BIOLOGY, 2020, 432 (02) : 305 - 323
  • [50] First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease
    Baaij, Marije
    van Galen, Karin P. M.
    Urbanus, Rolf T.
    Nigten, Jeannet
    Eikenboom, Jeroen H. C.
    Schutgens, Roger E. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (03) : 424 - 427